[Federal Register: June 9, 2009 (Volume 74, Number 109)]
[Notices]
[Page 27347]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09jn09-99]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    This is notice that on January 28, 2009, Stepan Company, Natural
Products Department, 100 W. Hunter Avenue, Maywood, New Jersey 07607,
made application by renewal to the Drug Enforcement Administration
(DEA) for registration as an importer of Coca Leaves (9040), a basic
class of controlled substance listed in schedule II.
    The company plans to import the listed controlled substance for the
manufacture of a bulk controlled substance for distribution to its
customer.
    No comments, objections, or requests for any hearings will be
accepted on any application for registration or re-registration to
import coca leaves. As explained in the Correction to Notice of
Application pertaining to Rhodes Technologies, 72 FR 3417 (2007),
comments and requests for hearings on applications to import narcotic
raw material are not appropriate.
    Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances listed in schedule I or II, which fall under the authority
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in
the circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR
1316.47.
    Any such comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, VA 22152; and must be filed no later
than July 9, 2009.
    This procedure is to be conducted simultaneously with and
independent of the procedures described in 21 CFR 1301.34(b), (c), (d),
(e), and (f). As noted in a previous notice published in the Federal
Register on September 23, 1975 (40 FR 43745), all applicants for
registration to import a basic class of any controlled substances in
schedule I or II are, and will continue to be, required to demonstrate
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, that the requirements for such
registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR
1301.34(b), (c), (d), (e), and (f) are satisfied.

    Dated: June 3, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-13353 Filed 6-8-09; 8:45 am]

BILLING CODE 4410-09-P